InvestorsHub Logo
Followers 4219
Posts 13632
Boards Moderated 6
Alias Born 12/14/2012

Re: AdamS007 post# 6811

Monday, 03/01/2021 3:56:23 AM

Monday, March 01, 2021 3:56:23 AM

Post# of 13625
UEEC: Of that there is little doubt.

With Friday's trading activity, closing unchanged at $1.14 on steady volume of 100,922 shares (the 90-day trading average is 114,866), the stock of United Health Products HAS PROVEN itself to be a STABLE INVESTMENT amongst the wider array of OTC equities that experienced sharp declines in trading last week.

This is a classic example of investors here KNOWING WHAT THEY OWN and, having done their extensive due diligence, are aware of the imminent FDA approval of HemoStyp® as a clotting agent for the more extensive use in surgical settings that will open a vastly LUCRATIVE market in the medical industry for this substantially superior hemostatic protocol.

Just a mere glance at the chart below is evidence of this stock's proven stability. Once the news hits, the price will escalate to at least $5.00, THEN the buyout negotiations from the larger pharmaceutical companies begin: THIS will be an EXCITING (and profitable) time for steadfast UEEC shareholders.

UEEC -Still holding Large..... FDA Approved and it's skyrocket time....



Chart: UEEC


Building on a Better Future, a Brighter Tomorrow

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent UEEC News